Literature DB >> 15450851

Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model.

David T Yeung1, Denis Josse, James D Nicholson, Akhil Khanal, Christopher W McAndrew, Brian J Bahnson, David E Lenz, Douglas M Cerasoli.   

Abstract

Human serum paraoxonase (HuPON1) is a calcium-dependent enzyme that hydrolyzes esters, including organophosphates and lactones, and exhibits anti-atherogenic properties. A few amino acids have been shown to be essential for the enzyme's arylesterase and organophosphatase activities. Until very recently, a three-dimensional model was not available for HuPON1, so functional roles have not been assigned to those residues. Based on sequence-structure alignment studies, we have folded the amino acid sequence of HuPON1 onto the sixfold beta-propeller structure of squid diisopropylfluorophosphatase (DFPase). We tested the validity of this homology model by circular dichroism (CD) spectroscopy and site-directed mutagenesis. Consistent with predictions from the homology model, CD data indicated that the structural composition of purified HuPON1 consists mainly of beta-sheets. Mutants of HuPON1 were assayed for enzymatic activity against phenyl acetate and paraoxon. Substitution of residues predicted to be important for substrate binding (L69, H134, F222, and C284), calcium ion coordination (D54, N168, N224, and D269), and catalytic mechanism of HuPON1 (H285) led to enzyme inactivation. Mutants F222Y and H115W exhibited substrate-binding selectivity towards phenyl acetate and paraoxon, respectively. The homology model presented here is very similar to the recently obtained PON1 crystal structure, and has allowed identification of several residues within the enzyme active site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450851     DOI: 10.1016/j.bbapap.2004.08.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods.

Authors:  Subramanian Barathi; Muralidaran Charanya; Shivashanmugam Muthukumaran; Narayanasamy Angayarkanni; Vetrivel Umashankar
Journal:  J Ocul Biol Dis Infor       Date:  2011-02-09

2.  Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound.

Authors:  Cheon Ho Park; Su Duy Nguyen; Mee Ree Kim; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

3.  Computational characterization of how the VX nerve agent binds human serum paraoxonase 1.

Authors:  Steven Z Fairchild; Matthew W Peterson; Adel Hamza; Chang-Guo Zhan; Douglas M Cerasoli; Wenling E Chang
Journal:  J Mol Model       Date:  2010-04-09       Impact factor: 1.810

4.  Computational Modeling of Human Paraoxonase 1: Preparation of Protein Models, Binding Studies, and Mechanistic Insights.

Authors:  Toby T Sanan; Sivaramakrishnan Muthukrishnan; Jeremy M Beck; Peng Tao; Carrigan J Hayes; Tamara C Otto; Douglas M Cerasoli; David E Lenz; Christopher M Hadad
Journal:  J Phys Org Chem       Date:  2010-04-01       Impact factor: 2.391

5.  Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes.

Authors:  Tamara C Otto; Christina K Harsch; David T Yeung; Thomas J Magliery; Douglas M Cerasoli; David E Lenz
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

6.  Rapid determination of hydrogen positions and protonation states of diisopropyl fluorophosphatase by joint neutron and X-ray diffraction refinement.

Authors:  Marc-Michael Blum; Marat Mustyakimov; Heinz Rüterjans; Kai Kehe; Benno P Schoenborn; Paul Langan; Julian C-H Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-09       Impact factor: 11.205

7.  IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood-brain barrier.

Authors:  Ruben J Boado; Yun Zhang; Yufeng Zhang; Yuntao Wang; William M Pardridge
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

Review 8.  Catalytic mechanisms for phosphotriesterases.

Authors:  Andrew N Bigley; Frank M Raushel
Journal:  Biochim Biophys Acta       Date:  2012-04-26

9.  Mechanistic Insights into the Hydrolysis of Organophosphorus Compounds by Paraoxonase-1: Exploring the Limits of Substrate Tolerance in a Promiscuous Enzyme.

Authors:  Sivaramakrishnan Muthukrishnan; Vivekanand S Shete; Toby T Sanan; Shubham Vyas; Shameema Oottikkal; Lauren M Porter; Thomas J Magliery; Christopher M Hadad
Journal:  J Phys Org Chem       Date:  2012-12       Impact factor: 2.391

10.  VX hydrolysis by human serum paraoxonase 1: a comparison of experimental and computational results.

Authors:  Matthew W Peterson; Steven Z Fairchild; Tamara C Otto; Mojdeh Mohtashemi; Douglas M Cerasoli; Wenling E Chang
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.